TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$119.15 USD
+4.86 (4.25%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $118.87 -0.28 (-0.23%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, TransMedics Group, Inc. has a market cap of $3.90B, which represents its share price of $114.29 multiplied by its outstanding shares number of 34.09M. As a mid-cap company, TMDX's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TMDX 119.15 +4.86(4.25%)
Will TMDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMDX
Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is TransMedics (TMDX) Down 1.9% Since Last Earnings Report?
Here's Why TransMedics (TMDX) is a Strong Momentum Stock
Here's Why TransMedics (TMDX) is a Strong Growth Stock
Other News for TMDX
TransMedics Group (TMDX): Evercore ISI Initiates Coverage with 'Outperform' Rating | TMDX Stock News
Apple initiated, Hershey upgraded: Wall Street’s top analyst calls
Apple initiated, Hershey upgraded: Wall Street's top analyst calls
TransMedics Group (TMDX) Has a New Rating from Roth MKM
Crossed Above 20 Day Moving Average appears for TMDX after 0.24% move